thiophenes has been researched along with Thrombopenia in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (19.23) | 18.7374 |
| 1990's | 2 (3.85) | 18.2507 |
| 2000's | 5 (9.62) | 29.6817 |
| 2010's | 24 (46.15) | 24.3611 |
| 2020's | 11 (21.15) | 2.80 |
| Authors | Studies |
|---|---|
| Markham, A | 1 |
| Al-Samkari, H; Jamieson, BD; Kolb-Sielecki, J; Safina, SZ; Xue, X | 1 |
| Arif, AR; Chen, W; Luo, S; Wang, Y; Xue, M; Zhao, M | 1 |
| Flamm, SL; Nilles, KM | 1 |
| Al-Samkari, H; Kuter, DJ; Virk, ZM | 1 |
| Al, M; Armstrong, N; Buksnys, T; Büyükkaramikli, N; Drachen, T; Duffy, S; Huertas Carrera, V; Kleijnen, J; Penton, H; Raatz, H; Riemsma, R; Ryder, S; Shah, D; Swift, S; Wetzelaer, P; Worthy, G | 1 |
| Gabrail, N; Smith, C | 1 |
| Lozano, ML | 1 |
| Buscarini, E; Dinis-Ribeiro, M; Fuccio, L; Hassan, C; Radaelli, F | 1 |
| Bussel, JB; Lee, EJ; Seshadri, M | 1 |
| Bubalo, J; Gilreath, J; Lo, M | 1 |
| Ferry, J; Hussein, Z; Nomoto, M | 1 |
| Shirley, M | 1 |
| Aschenbrenner, DS | 1 |
| Allen, LF; Kuter, DJ | 1 |
| Carmichael, SL; Forde, EE; Frelinger, AL; Michelson, AD; Smolensky Koganov, E | 1 |
| Weinberg, EM | 1 |
| Al-Samkari, H | 1 |
| Al-Horani, RA; Clemons Bankston, P | 1 |
| Bock, F; Hartung, K; Isermann, B; Meyer, F | 1 |
| Crowther, MA; Linkins, LA; Manji, RA; Pai, M; Shivakumar, S; Warkentin, TE; Wells, PS | 1 |
| Ng, HJ; Teo, EC; Than, H | 1 |
| Hassanein, T; Howell, CD; Jenkins, TM; Joshi, S; Lake, J; McIntosh, J; Sher, L; Tang, S; Terrault, NA; Vargas, H | 1 |
| Bissonnette, J; Rautou, PE; Valla, D | 1 |
| Hantson, P; Hermans, C; Lambert, C | 1 |
| Mima, Y; Nagata, S; Okada, Y; Sangatsuda, Y; Wakugawa, Y; Yasaka, M | 1 |
| Linkins, LA; Warkentin, TE | 1 |
| Bakchoul, T; Ganzel, C; Greinacher, A; Rowe, JM; Tvito, A | 1 |
| Loh, JB; Ng, HJ; Sum, CL; Than, H | 1 |
| Bianchi, CF; Petrucci, O | 1 |
| Abouassi, S; Abouchakra, L; Badaoui, G; Khabbaz, Z | 1 |
| de Knegt, RJ; Maan, R; Veldt, BJ | 1 |
| Abe, M; Fukushima-Shintani, M; Hirayama, F; Iwatsuki, Y; Kawasaki, T; Sugasawa, K; Suzuki, K | 1 |
| Bakhos, M; Hoppensteadt, D; Iqbal, O; Jeske, WP; Maddineni, J; Messmore, HL; Prechel, M; Walenga, JM | 1 |
| Castro, RA; Lima, CC; Moraes, MB; Santos, VM; Sugai, TA | 1 |
| Fürll, B; Greinacher, A; Hackbarth, C; Krauel, K | 1 |
| Favaloro, EJ; Lippi, G | 1 |
| Blanchard, J; Panak, E; Roe, RL | 1 |
| Butler, KD; White, AM | 1 |
| Claas, FH; de Fraiture, WH; Meyboom, RH | 1 |
| Curtet, JM; Guilmet, D; Renner, C | 1 |
| Douglass, HO; Kelsen, DP; Meropol, NJ; Pazdur, R; Vincent, M; Willson, JK | 1 |
| Blay, JY; Hermans, C; Judson, I; Rodenhuis, S; Smith, M; van Glabbeke, M; Verweij, J | 1 |
| Aherne, GW; Brunton, L; Clarke, SJ; Farrugia, DC; Jackman, AL | 1 |
| Danese, M; Martin, XD | 1 |
| Buchholz, E; Kloeppel, R; Kreisel, C; Manegold, C; Smith, M | 1 |
| Abiko, Y; Ashida, S; Kakihata, K; Tomikawa, M | 1 |
| Alberca, I; Cattaneo, M; Coccato, MP; Faioni, E; Mannucci, PM; Mari, D; Vianello, L; Vicente, V | 1 |
| Hatsuoka, M; Kashii, A; Sasaki, K; Seiki, M | 1 |
| Almeida-Dias, A; Pina-Cabral, JM; Ribeiro-da-Silva, A | 1 |
| Ackles, KN; Inwood, MJ; Philp, RB; Radomski, MW | 1 |
| Hansen, HH; Muggia, FM; Selawry, OS | 1 |
11 review(s) available for thiophenes and Thrombopenia
| Article | Year |
|---|---|
Avatrombopag: A Review in Thrombocytopenia.
Topics: Adult; Animals; Chronic Disease; Humans; Liver Diseases; Purpura, Thrombocytopenic, Idiopathic; Receptors, Thrombopoietin; Thiazoles; Thiophenes; Thrombocytopenia | 2021 |
Thrombocytopenia in Chronic Liver Disease: New Management Strategies.
Topics: Chronic Disease; Cinnamates; Hemorrhage; Humans; Liver Diseases; Platelet Count; Platelet Transfusion; Receptors, Thrombopoietin; Risk Factors; Surgical Procedures, Operative; Thiazoles; Thiophenes; Thrombocytopenia; Thrombopoiesis | 2020 |
Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.
Topics: Bayes Theorem; Cinnamates; Clinical Trials as Topic; Cost-Benefit Analysis; End Stage Liver Disease; Humans; Models, Economic; Platelet Transfusion; Quality-Adjusted Life Years; Receptors, Thrombopoietin; Secondary Care; Technology Assessment, Biomedical; Thiazoles; Thiophenes; Thrombocytopenia | 2020 |
Avatrombopag for the management of thrombocytopenia in patients with chronic liver disease.
Topics: Adult; Chronic Disease; Humans; Liver Diseases; Thiazoles; Thiophenes; Thrombocytopenia | 2021 |
Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists.
Topics: Benzoates; Cinnamates; Dose-Response Relationship, Drug; Drug Monitoring; Health Knowledge, Attitudes, Practice; Humans; Hydrazines; Pharmacists; Platelet Count; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thiazoles; Thiophenes; Thrombocytopenia; Thrombopoietin | 2021 |
Avatrombopag: First Global Approval.
Topics: Chronic Disease; Drug Approval; Humans; Liver Diseases; Receptors, Thrombopoietin; Thiazoles; Thiophenes; Thrombocytopenia; United States; United States Food and Drug Administration | 2018 |
Avatrombopag maleate for the treatment of periprocedural thrombocytopenia in patients with chronic liver disease.
Topics: Animals; Chronic Disease; Drug Interactions; Hematologic Agents; Humans; Liver Diseases; Perioperative Period; Thiazoles; Thiophenes; Thrombocytopenia; Treatment Outcome | 2018 |
New Small Molecule Drugs for Thrombocytopenia: Chemical, Pharmacological, and Therapeutic Use Considerations.
Topics: Aminopyridines; Animals; Cinnamates; Drug Development; Humans; Morpholines; Oxazines; Pyridines; Pyrimidines; Receptors, Thrombopoietin; Small Molecule Libraries; Syk Kinase; Thiazoles; Thiophenes; Thrombocytopenia | 2019 |
[From heparin to apixaban: anticoagulants cut both ways?].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Blood Coagulation Tests; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Fondaparinux; Heparin; Humans; International Normalized Ratio; Liver Failure; Metabolic Clearance Rate; Morpholines; Perioperative Care; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency; Rivaroxaban; Thiophenes; Thrombocytopenia; Thrombosis; Vitamin K | 2014 |
Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.
Topics: Benzoates; Chronic Disease; Disease Management; Hepatitis C, Chronic; Humans; Hydrazines; Liver Diseases; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thiazoles; Thiophenes; Thrombocytopenia; Thrombopoietin | 2015 |
Dorzolamide-induced immune thrombocytopenia: a case report and literature review.
Topics: Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Glaucoma, Open-Angle; Humans; Male; Platelet Count; Sulfonamides; Thiophenes; Thrombocytopenia | 2001 |
12 trial(s) available for thiophenes and Thrombopenia
| Article | Year |
|---|---|
Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial.
Topics: Adolescent; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Humans; Neutropenia; Thiazoles; Thiophenes; Thrombocytopenia; Treatment Outcome | 2022 |
Avatrombopag, an oral thrombopoietin receptor agonist: results of two double-blind, dose-rising, placebo-controlled Phase 1 studies.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Receptors, Thrombopoietin; Thiazoles; Thiophenes; Thrombocytopenia | 2018 |
Avatrombopag increases platelet count but not platelet activation in patients with thrombocytopenia resulting from liver disease.
Topics: Blood Platelets; Chronic Disease; Double-Blind Method; Hematologic Agents; Humans; Liver Diseases; Platelet Activation; Platelet Count; Thiazoles; Thiophenes; Thrombocytopenia; Thrombopoiesis; Time Factors; Treatment Outcome; United States | 2018 |
Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure.
Topics: Blood Platelets; Dose-Response Relationship, Drug; Double-Blind Method; Elective Surgical Procedures; Fatigue; Female; Headache; Humans; Incidence; Liver Cirrhosis; Male; Middle Aged; Nausea; Platelet Count; Receptors, Thrombopoietin; Risk Factors; Thiazoles; Thiophenes; Thrombocytopenia | 2014 |
Evaluation of the antithrombotic efficacy of ticlopidine in man.
Topics: Anticoagulants; Clinical Trials as Topic; Extracorporeal Circulation; Female; Fibrinolytic Agents; Humans; Leukocyte Count; Male; Premedication; Renal Dialysis; Thiophenes; Thrombocytopenia; Thrombosis; Ticlopidine | 1984 |
[Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)].
Topics: Adolescent; Adult; Aged; Blood Coagulation; Cardiac Surgical Procedures; Extracorporeal Circulation; Humans; Middle Aged; Platelet Aggregation; Postoperative Complications; Pyridines; Thiophenes; Thrombocytopenia; Thrombosis; Ticlopidine | 1980 |
Phase II study of ZD1694 in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Alanine Transaminase; Antimetabolites, Antineoplastic; Aspartate Aminotransferases; Asthenia; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Mucous Membrane; Nausea; Neoplasm Staging; Quinazolines; Remission Induction; Stomach Neoplasms; Thiophenes; Thrombocytopenia; Thymidylate Synthase; Vomiting | 1996 |
Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Quinazolines; Sarcoma; Soft Tissue Neoplasms; Thiophenes; Thrombocytopenia; Treatment Outcome | 1999 |
Phase I dose-escalating study of raltitrexed ('Tomudex') and cisplatin in metastatic non-small cell lung cancer.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Quinazolines; Thiophenes; Thrombocytopenia | 2002 |
Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time.
Topics: Adolescent; Adult; Aged; Aspirin; Bleeding Time; Clinical Trials as Topic; Deamino Arginine Vasopressin; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Platelet Function Tests; Random Allocation; Thiophenes; Thrombocytopenia; Ticlopidine; von Willebrand Factor | 1986 |
Effects of decompression on platelets and hemostasis in men and the influence of antiplatelet drugs (RA233 and VK744).
Topics: Adenosine Diphosphate; Adult; Aspartate Aminotransferases; Atmosphere Exposure Chambers; Atmospheric Pressure; Blood Cell Count; Blood Platelets; Cholinesterases; Clinical Trials as Topic; Creatine Kinase; Decompression Sickness; Epinephrine; Ethanolamines; Hematopoiesis; Hemostasis; Humans; L-Lactate Dehydrogenase; Male; Morpholines; Piperidines; Platelet Adhesiveness; Pyrimidines; Thiophenes; Thrombin; Thrombocytopenia; Time Factors | 1974 |
Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819).
Topics: Aged; Antineoplastic Agents; Astrocytoma; Clinical Trials as Topic; Esophageal Neoplasms; Evaluation Studies as Topic; Fibroblasts; Glycosides; Humans; Hypotension; Lactones; Leiomyosarcoma; Leukopenia; Liver Neoplasms; Lung Neoplasms; Melanoma; Middle Aged; Mitosis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Structure-Activity Relationship; Thiophenes; Thrombocytopenia | 1971 |
29 other study(ies) available for thiophenes and Thrombopenia
| Article | Year |
|---|---|
Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.
Topics: Benzoates; Hearing Loss, Sensorineural; Humans; Hydrazines; Male; Molecular Motor Proteins; Mutation; Myosin Heavy Chains; Pyrazoles; Thiazoles; Thiophenes; Thrombocytopenia; Treatment Failure | 2022 |
An evaluation of avatrombopag for the treatment of thrombocytopenia.
Topics: Humans; Liver Diseases; Purpura, Thrombocytopenic, Idiopathic; Thiazoles; Thiophenes; Thrombocytopenia | 2021 |
Avatrombopag Optimizes Response to Niraparib by Managing Thrombocytopenia Associated with Poly-ADP Ribose Polymerase (PARP) Inhibition in Ovarian Cancer and Breast Cancer: A Case Series.
Topics: Adenosine Diphosphate Ribose; Breast Neoplasms; Female; Humans; Indazoles; Ovarian Neoplasms; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Thiazoles; Thiophenes; Thrombocytopenia | 2020 |
Second-generation thrombopoietin receptor agonists: New players in the management of cirrhotic patients undergoing therapeutic endoscopy?
Topics: Cinnamates; Endoscopy; Humans; Liver Cirrhosis; Receptors, Thrombopoietin; Surveys and Questionnaires; Thiazoles; Thiophenes; Thrombocytopenia | 2021 |
Clinical outcomes in eight patients with immune thrombocytopenia each treated with the three approved thrombopoietin receptor agonists.
Topics: Adult; Aged; Benzoates; Female; Humans; Hydrazines; Male; Middle Aged; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thiazoles; Thiophenes; Thrombocytopenia; Thrombopoietin; Treatment Outcome | 2021 |
Population Pharmacokinetic/Pharmacodynamic Analyses of Avatrombopag in Patients With Chronic Liver Disease and Optimal Dose Adjustment Guide With Concomitantly Administered CYP3A and CYP2C9 Inhibitors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Computer Simulation; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; End Stage Liver Disease; Female; Humans; Male; Middle Aged; Models, Biological; Thiazoles; Thiophenes; Thrombocytopenia; Young Adult | 2018 |
First Drug Approved to Reduce Bleeding Risk During Medical Procedures in Patients with Chronic Liver Disease.
Topics: Drug Approval; End Stage Liver Disease; Humans; Receptors, Thrombopoietin; Thiazoles; Thiophenes; Thrombocytopenia | 2018 |
What Did We Learn From the ADAPT Trials?
Topics: Humans; Liver Diseases; Platelet Transfusion; Thiazoles; Thiophenes; Thrombocytopenia | 2019 |
Design of the rivaroxaban for heparin-induced thrombocytopenia study.
Topics: Anticoagulants; Cohort Studies; Factor Xa Inhibitors; Heparin; Humans; Morpholines; Prospective Studies; Research Design; Rivaroxaban; Thiophenes; Thrombocytopenia | 2014 |
First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.
Topics: Aged; Blood Coagulation; Factor Xa Inhibitors; Female; Heparin; Heparin Antagonists; Humans; Kidney Failure, Chronic; Male; Middle Aged; Morpholines; Peripheral Vascular Diseases; Platelet Count; Renal Dialysis; Rivaroxaban; Thiophenes; Thrombocytopenia; Venous Thrombosis | 2015 |
Managing periprocedural thrombocytopenia in cirrhosis: aiming for a safety window.
Topics: Elective Surgical Procedures; Female; Humans; Liver Cirrhosis; Male; Receptors, Thrombopoietin; Thiazoles; Thiophenes; Thrombocytopenia | 2014 |
Rivaroxaban for arterial thrombosis related to heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Factor Xa Inhibitors; Heparin; Humans; Male; Morpholines; Rivaroxaban; Thiophenes; Thrombocytopenia; Thrombosis | 2015 |
Acute thrombocytopenia after initiating anticoagulation with rivaroxaban.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Humans; Intracranial Hemorrhages; Male; Morpholines; Rivaroxaban; Stroke; Thiophenes; Thrombocytopenia; Warfarin | 2014 |
Rivaroxaban for treatment of HIT: a riveting first experience.
Topics: Factor Xa Inhibitors; Female; Heparin; Heparin Antagonists; Humans; Male; Morpholines; Rivaroxaban; Thiophenes; Thrombocytopenia | 2015 |
Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.
Topics: Aged, 80 and over; Antibodies; Anticoagulants; Blood Platelets; Dalteparin; Female; Fondaparinux; Hip Fractures; Hirudins; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Morpholines; Peptide Fragments; Platelet Count; Polysaccharides; Recombinant Proteins; Rivaroxaban; Thiophenes; Thrombocytopenia; Venous Thrombosis | 2015 |
Clinical utility of anti-Xa monitoring and differential sensitivity of prothrombin time assays: an illustrated case report.
Topics: Administration, Oral; Blood Coagulation; Drug Monitoring; Factor Xa Inhibitors; Female; Heparin; Humans; International Normalized Ratio; Middle Aged; Morpholines; Predictive Value of Tests; Prothrombin Time; Reproducibility of Results; Rivaroxaban; Thiophenes; Thrombocytopenia; Time Factors; Treatment Outcome; Warfarin | 2015 |
Another off-label novel oral anticoagulant to HIT cardiac surgery patients.
Topics: Anticoagulants; Coronary Artery Bypass; Factor Xa Inhibitors; Graft Occlusion, Vascular; Heparin; Humans; Male; Morpholines; Saphenous Vein; Thiophenes; Thrombocytopenia; Thrombosis | 2015 |
Rivaroxaban for treatment of heparin-induced thrombocytopenia after cardiac surgery: A case report.
Topics: Anticoagulants; Coronary Artery Bypass; Factor Xa Inhibitors; Graft Occlusion, Vascular; Heparin; Humans; Male; Middle Aged; Morpholines; Off-Label Use; Platelet Count; Radiography; Rivaroxaban; Saphenous Vein; Thiophenes; Thrombocytopenia; Thrombosis; Treatment Outcome | 2015 |
AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.
Topics: Antigens, CD; Antigens, CD34; Blood Platelets; Cells, Cultured; Colony-Forming Units Assay; Flow Cytometry; Humans; Piperidines; Receptors, Thrombopoietin; Thiazoles; Thiophenes; Thrombocytopenia; Thrombopoiesis; Thrombopoietin | 2008 |
Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.
Topics: Analysis of Variance; Anticoagulants; Antithrombin III; Arginine; Autoantibodies; Enoxaparin; Flow Cytometry; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Morpholines; Pipecolic Acids; Platelet Activation; Platelet Aggregation; Platelet Factor 4; Polysaccharides; Rivaroxaban; Sulfonamides; Thiophenes; Thrombocytopenia | 2008 |
Skin eruption and thrombocytopaenia in a woman with glaucoma: a case report.
Topics: Anti-Infective Agents; Antihypertensive Agents; Biopsy; Dapsone; Drug Eruptions; Female; Glaucoma; Humans; Liver Function Tests; Middle Aged; Ophthalmic Solutions; Platelet Count; Sulfonamides; Thiophenes; Thrombocytopenia; Timolol | 2010 |
Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
Topics: Antibodies; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Cells; Cells, Cultured; Dabigatran; Drug Evaluation, Preclinical; Drug Interactions; HEK293 Cells; Heparin; Humans; Morpholines; Platelet Factor 4; Rivaroxaban; Sulfates; Thiophenes; Thrombocytopenia; Transfection | 2012 |
Coagulopathies and thrombosis: usual and unusual causes and associations, part VI.
Topics: Acute Coronary Syndrome; Altitude; Blood Coagulation Disorders; Coffee; Factor Xa Inhibitors; Heparin; Humans; Lipoproteins; Lymphatic Diseases; Morpholines; Myocardial Infarction; Platelet Aggregation Inhibitors; Rivaroxaban; Thiophenes; Thrombocytopenia; Thrombosis; Troponin; Venous Thrombosis; von Willebrand Diseases | 2012 |
Inhibition of thrombocytopenic episodes caused by the Arthus reaction, the sub-lethal Forssman reaction and ADP.
Topics: Adenosine Diphosphate; Animals; Antibodies; Arthus Reaction; Aspirin; Dipyridamole; Forssman Antigen; Guinea Pigs; Humans; Nervous System Diseases; Platelet Count; Pyridines; Sulfides; Sulfinpyrazone; Thiophenes; Thrombocytopenia; Ticlopidine | 1980 |
[Thrombocytopenia due to antibodies induced by ticlopidine].
Topics: Aged; Antibody Formation; Anticoagulants; Arteriosclerosis; Blood Platelets; Humans; Platelet Count; Thiophenes; Thrombocytopenia; Ticlopidine | 1984 |
Leucovorin rescue from raltitrexed (tomudex)-induced antiproliferative effects: in vitro cell line and in vivo mouse studies.
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Cell Division; Cell Line; Drug Interactions; Humans; Intestinal Mucosa; Intestine, Small; Leucovorin; Leukemia L1210; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Neutropenia; Polyglutamic Acid; Quinazolines; Thiophenes; Thrombocytopenia | 2000 |
Anti-thrombotic action of ticlopidine, a new platelet aggregation inhibitor.
Topics: Acute Disease; Aminopropionitrile; Animals; Blood Coagulation; Collagen; Lactates; Lung Diseases; Male; Platelet Aggregation; Pyridines; Rats; Thiophenes; Thrombocytopenia; Thrombosis | 1978 |
Hemostatic effects of microfibrillar collagen hemostat (MCH) in experimental coagulopathy model and its mechanism of hemostasis.
Topics: Animals; Aspirin; Blood Coagulation Disorders; Cattle; Collagen; Dogs; Hemorrhage; Hemostatic Techniques; Hemostatics; Heparin; Spleen; Thiophenes; Thrombocytopenia; Ticlopidine; Warfarin | 1986 |
Platelet sequestration during hypothermia in dogs treated with sulphinpyrazone and ticlopidine--reversibility accelerated after intra-abdominal rewarming.
Topics: Animals; Blood Platelets; Dogs; Hemodynamics; Hot Temperature; Hypothermia; Liver; Platelet Aggregation; Sulfinpyrazone; Thiophenes; Thrombocytopenia; Ticlopidine | 1985 |